172 filings
Page 4 of 9
8-K
ex9yqk7t
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am
8-K
000wk22
11 Feb 21
Other Events
5:01pm
8-K
71kijm1qqwz 5r3
31 Dec 20
Entry into a Material Definitive Agreement
4:31pm
8-K
z2ybf21urlul
2 Nov 20
Regulation FD Disclosure
9:22am
8-K
ttqksox
30 Oct 20
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
8:00am
8-K
drp 6bsy27iei
13 Aug 20
Trevena Announces Pricing of $50 Million Public Offering of Common Stock
12:00am
8-K
qt4sj1
11 Aug 20
Trevena Announces Proposed Public Offering of Common Stock
4:28pm
8-K
u7u7fz2evc3tpx ghg
10 Aug 20
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
6:24am
8-K
goxjf981 s8t
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
a1w58knyxvd
26 May 20
Other Events
4:05pm
8-K
58a2bf6
18 May 20
Regulation FD Disclosure
5:21pm
8-K
50dwj
18 May 20
Regulation FD Disclosure
7:00am
8-K
plpqjp6d3t5al
15 May 20
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
ekmr86u lcabwmu1z
7 May 20
Trevena Reports First Quarter 2020 Results
7:05am
8-K
5q2jm qehmk6ldpx1k
20 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:30am
8-K
ohxjiolndxm9snad
26 Mar 20
Other Events
7:00am
8-K
c7ip opxfuccxnlv3
13 Mar 20
Trevena Reports Fourth Quarter and Full Year 2019 Results
7:00am
8-K
ti5li16hml1jgl5g
5 Mar 20
FDA considers NDA resubmission a complete Class 2 response
7:05am
8-K
0q9qt aymj0w5y5
4 Mar 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
63929z2
14 Feb 20
Trevena Appoints Scott Applebaum as Chief Legal and Compliance Officer and SVP of Regulatory Affairs
4:02pm